Gene · 10801
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Electrochemical detection of circulating-free DNA methylation: A new indicator for early cancer screening. | Talanta | 2025 | 40081249 | PubTator, text mining | PubMed |
| Diagnostic accuracy of methylated SEPT9 for primary liver cancer: a systematic review and meta-analysis. | Front Endocrinol (Lausanne) | 2025 | 40017695 | PubTator, text mining | PubMed |
| Accuracy and long-term effectiveness of established screening modalities and strategies in colorectal cancer screening: An umbrella review. | Int J Cancer | 2025 | 39998407 | PubTator, text mining | PubMed |
| SEPT14 complexes maintain sperm morphogenesis and function. | FASEB J | 2025 | 39982757 | PubTator, text mining | PubMed |
| Sensitive detection of circulating methylated SEPT9 in hepatocellular carcinoma patients using a novel quantitative PCR assay. | Anal Methods | 2025 | 39962989 | PubTator, text mining | PubMed |
| Innovative approaches in colorectal cancer screening: advances in detection methods and the role of artificial intelligence. | Ther Adv Gastroenterol | 2025 | 39898356 | PubTator, text mining | PubMed |
| Fragment-specific Quantification of 5hmC by qPCR via a Combination of Enzymatic Digestion and Deamination: Extreme Specificity, High Sensitivity, and Clinical Applicability. | Anal Chem | 2025 | 39804214 | PubTator, text mining | PubMed |
| The role of ctDNA from liquid biopsy in predicting survival outcomes in HPV-negative head and neck cancer: A meta-analysis. | Oral Oncol | 2025 | 39742703 | PubTator, text mining | PubMed |
| Corrigendum to "The first attempt in synthesis, identification, and evaluation of SEPT9 inhibitors on human oral squamous carcinomas" [Bioorg. Chem 154 (2025) 108068]. | Bioorg Chem | 2025 | 39741018 | PubTator, text mining | PubMed |
| The first attempt in synthesis, identification, and evaluation of SEPT9 inhibitors on human oral squamous carcinomas. | Bioorg Chem | 2025 | 39705938 | PubTator, text mining | PubMed |
| Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma. | J Clin Pathol | 2025 | 39060112 | PubTator, text mining | PubMed |
| Diagnostic value of methylated SEPT9 and RNF180 for gastric cancer in high-risk population: a multi-centre retrospective study in Yunnan, Southwest China. | Arch Med Sci | 2024 | 39967944 | PubTator, text mining | PubMed |
| A multi-gene blood-based methylation assay for early diagnosis of colorectal cancer. | Transl Cancer Res | 2024 | 39816546 | PubTator, text mining | PubMed |
| Investigation of the expression level of methylated septin 9 gene and serological carcinoembryonic antigen to diagnose colorectal cancer. A meta-analysis study. | Prz Gastroenterol | 2024 | 39810876 | PubTator, text mining | PubMed |
| A Role of Inflammation in Charcot-Marie-Tooth Disorders-In a Perspective of Treatment? | Int J Mol Sci | 2024 | 39795872 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of a Blood-Based Biomarker Panel for Colorectal Cancer Detection: A Pilot Study. | Cancers (Basel) | 2024 | 39766076 | PubTator, text mining | PubMed |
| Extensive methylation analysis of circulating tumor DNA in plasma of patients with gastric cancer. | Sci Rep | 2024 | 39730450 | PubTator, text mining | PubMed |
| Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA. | BMC Cancer | 2024 | 39725880 | PubTator, text mining | PubMed |
| Comparative analysis of SDC2 and SEPT9 methylation tests in the early detection of colorectal cancer: a systematic review and meta-analysis. | Front Med (Lausanne) | 2024 | 39717169 | PubTator, text mining | PubMed |
| Rearranging to resist cell death. | Elife | 2024 | 39680433 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10801/papers?page=7